A detailed history of Cookson Peirce & CO Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 7,000 shares of ARVN stock, worth $173,810. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,000
Holding current value
$173,810
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$36.38 - $52.31 $254,660 - $366,170
7,000 New
7,000 $289,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.32B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.